Anticarcinogenic Agents

DBCAT000369Pharmacologic class

Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. A DrugBank category of 25 drugs. 2 of them are approved.

Also known as: Agents, Anti-Carcinogenic · Agents, Anticarcinogenic · Anti Carcinogenic Agents · Anti Carcinogenic Drugs · Anti Carcinogenic Effect
Drugs: 3,3'-diindolylmethane
3,4-Dihydroxybenzoic Acid
Besigomsin
Biochanin A
Cholesterol sulfate
Ecabet
Epigallocatechin gallate
Exisulind
Fenretinide
Garlic oil
Genistein
Indole-3-carbinol
Irsogladine
Lycopene
Maxacalcitol
Methylselenocysteine
Oltipraz
Peretinoin
Phenethyl Isothiocyanate
Resveratrol
Squalamine
Sulforaphane
Transcrocetinate
Vitamin A
Zuretinol acetate

What you can answer from here — as of August 24, 2016

25DrugsEach linked to its full drug card

Listed above

151Drug targetsEvery drug–target pair in the class, with bond type

1,149Marketed productsAcross the regions we cover, with dosage forms and routes

9Routes of administrationHow the drugs in this class are given

Which targets do Anticarcinogenic Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account